<GlossaryTerm id="CDR0000306513"><TermName>rasburicase</TermName><TermPronunciation>(ras-BYOOR-ih-kays)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat high levels of uric acid in the blood of adults and children with leukemia, lymphoma, or other types of cancer who are receiving certain types of anticancer therapy. Uric acid is a natural substance that can build up in the blood as tumors break down. Rasburicase helps break down and remove uric acid from the body. It is a type of recombinant enzyme and a type of urate-lowering drug. Also called Elitek and recombinant urate oxidase.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000711504" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;rasburicase&quot;" language="en" id="_3"/><MediaLink ref="CDR0000711503" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;rasburicasa&quot;" language="es" id="_4"/><SpanishTermName>rasburicasa</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para el tratamiento de las concentraciones altas de ácido úrico en la sangre de adultos y niños  que reciben ciertos tipos de tratamientos para la leucemia, el linfoma y otros tipos de cáncer. El ácido úrico es una sustancia natural que a veces se acumula en la sangre cuando  se está destruyendo un tumor. El rasburicase ayuda a descomponer y eliminar el ácido úrico del cuerpo. Es un tipo de  enzima recombinante y de fármaco urolítico. También se llama Elitex y urato–oxidasa recombinante.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2003-05-23</DateFirstPublished><DateLastModified>2021-03-26</DateLastModified><RelatedInformation><RelatedDrugSummaryRef UseWith="en" href="CDR0000658556" url="/about-cancer/treatment/drugs/rasburicase">Rasburicase</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
